All Episodes
Listen to Gynecologic Oncology — 72 episodes
FIGO 2023 Upstaging: Overtreatment or Overdue Precision?
ERAS 2026: Key Updates Every Gynecologic Oncologist Should Know
Beyond the Binary: Unpacking Molecular Diversity in PMMR Endometrial Cancer
Cologuard-like test for identification of endometrial cancer through vaginal sampling
PARP Inhibitors in Ovarian Cancer: A Society of Gynecologic Oncology Podcast
Home the Same Day? Testing the Limits in Ovarian Cancer Debulking Surgery
Recognizing and Managing ADC-Associated Pulmonary Toxicities
In good SHAPE
ctDNA-Guided PARPi Therapy in Ovarian Cancer
Beyond treatment: The who, why, when, where and what of cancer follow up
Ovarian Cancer After Breast Cancer in Women with BRCA Variants
Making a difference: Molecules, mechanisms and more
Navigating Surgical Complexity After Ovarian Cancer Neoadjuvant Chemotherapy
Cervical Cancer Care in Focus: Consensus on Quality, Equity, and Radiation Therapy
Beyond Anesthesia: Self-Hypnosis in ERAS Programs
Carcinosarcoma Wars: A New Hope for TROP-2 Therapeutic Targeting
To divert or not to divert: that is the question
A randomized clinical trial of metformin in endometrial cancer
Understanding the Implications of the Platinum-Free Interval in Endometrial Cancer
Prophylactic chemotherapy to prevent post-molar gestational trophoblastic disease - a long journey and a remarkable study
Clinical trials: Panacea or pitfall
FOLR1 status: Landscape beyond high grade serous ovarian cancer
Benefits of hormonal therapy for low grade serous ovarian cancer
Implementation and impact of a financial navigation program in gynecologic oncology
LVSI in Stage 1 Endometrial Cancer
Primary Surgery versus Radiotherapy for Inguinal Lymph Nodes in Vulvar Cancer
2023 FIGO staging for endometrial cancer: a reappraisal on the path to continuous improvement
Shifting trends and sicker patients - the future of gynecologic cancer
SENTIREC-endo study: Is the juice worth the squeeze?
Caring for the Caregiver
Lunchbox Trial
Optimization of endometrial cancer survivorship through modification of lifestyle factors
Engagement with ERAS patients leads to improved outcomes
OS updates for Imagyn50
Is now the time to begin thromboprophylaxis for all patients with advanced ovarian cancer, including those undergoing neoadjuvant chemotherapy?
What is your center doing to improve genetic testing following abnormal MMR results in endometrial cancer?
The evolution of patient-centered endometrial cancer detection: testing tompon-based collection for methylated DNA markers
TKI Toxicities: A Society of Gynecologic Oncology Podcast
ERAS Society Updates: What Every Gyn Oncologist Should Know
Prioritizing and achieving diversity in clinical trial enrollment
The times they are a changin’ – the future of the specialty
Intrathoracic Surgery and Ovarian Cancer Cytoreduction: Why the Chest Matters
A Geo-Analyzer Tool that assessed insured patients in your metropolitan area with recurrent and metastatic cervix cancer
Molecular Testing for Endometrial Cancer: A Society of Gynecologic Oncology Podcast
Sentinel lymph node mapping in endometrial complex atypical hyperplasia: good idea or have we gone too far?
Burnout and gynecologic oncology - does the problem still exist?
Exceptional PARP inhibitor responders: the good and the bad
Management of primary low-grade serous ovarian carcinoma: are you up-to-date on the most contemporary prognostic factors and treatment strategies?
How do you manage the contralateral groin in early stage vulvar cancer with a unilateral positive sentinel lymph node?
Frailty assessment in gynecologic oncology - have you incorporated this into your practice?
Complications after cytoreductive surgery and its impact on survival: where do we go from here?
Immunotherapy Toxicities: A Society of Gynecologic Oncology Podcast
Long-term cardiovascular complications among gynecologic cancer survivors
Financial toxicity – the other side effect of cancer care
Reducing non-surgical readmissions in gynecologic oncology
Improving QOL for patients with cervical cancer: SLN biopsy
The ProMisE of molecular classification to standardize care in endometrial cancer
HRD: What does it really mean and are we looking at this the right way?
Optimizing Rural Ovarian Cancer Care
Recurrent Endometrial Cancer: A Society of Gynecologic Oncology Podcast
Looking Back at 2021: November Editor’s Choice
Differences in cervical cancer screening and follow-up for black and white women in the United States
March 2021: The Future Of Gynecologic Oncology: We are at a Crossroads
April 2020: Rare Tumors and Conditions
2020 Virtual Annual SGO Meeting Report
PARP Inhibitor Maintenance Therapy after Initial Chemotherapy for Advanced Ovary, Fallopian Tube and Primary Peritoneal Cancers
Present and Future Impact of COVID-19 on the Practice and Delivery on Gynecologic Oncology Care
Financial hardship among gynecologic cancer patients
Does the transcriptome of ovarian neoplasms provide insight into its potential behavior?
December 2019 Editor's Choice
Survival of endometrial cancer patients following lymphadenectomy or sentinel node procedure
Inaugural Gynecologic Oncology Podcast - When to stop hCG surveillance following chemotherapy for gastational trophoblastic neoplasia